Invenomic Capital Management’s Fiserv Inc FISV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Buy
624,991
+337,725
+118% +$20.9M 1.6% 16
2025
Q4
$19.3M Buy
+287,266
New +$24M 0.9% 38
2023
Q3
Sell
-65,504
Closed -$8.26M 154
2023
Q2
$8.26M Sell
65,504
-137,656
-68% -$16.2M 0.42% 66
2023
Q1
$23M Buy
203,160
+121,118
+148% +$13.3M 1.3% 26
2022
Q4
$8.29M Sell
82,042
-39,062
-32% -$3.89M 0.56% 60
2022
Q3
$11.3M Sell
121,104
-3,432
-3% -$350K 0.97% 37
2022
Q2
$11.1M Buy
124,536
+41,095
+49% +$3.99M 0.79% 43
2022
Q1
$6.98M Buy
83,441
+49,303
+144% +$4.99M 0.74% 40
2021
Q4
$3.54M Buy
+34,138
New +$3.53M 0.76% 51

Other funds holding FISV

Invenomic Capital Management's FISV Position: Q1 2026 in Review

Invenomic Capital Management increased its Fiserv Inc (FISV) stake by 118% in Q1 2026, buying an estimated $20.9M and bringing the position to 624,991 shares worth $34.9M. The position accounts for 1.6% of the portfolio, ranked #16.

Invenomic Capital Management first reported a position in FISV in Q4 2021 and has held it in 9 quarters since. 1,255 funds tracked by Wall St. Rank hold FISV as of Q1 2026.

  • Invenomic Capital Management held 624,991 shares of Fiserv Inc worth $34.9M as of Q1 2026.
  • Invenomic Capital Management bought 337,725 Fiserv Inc shares in Q1 2026, an estimated $20.9M.
  • Fiserv Inc made up 1.6% of Invenomic Capital Management's portfolio in Q1 2026, its #16 holding.
  • Invenomic Capital Management first reported a position in Fiserv Inc in Q4 2021 and has held it in 9 quarters since.
  • 1,255 funds tracked by Wall St. Rank held Fiserv Inc as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.